Abstract
Background Herpesvirus infections may trigger Autoimmune neuroinflammatory diseases (ANDs), but their causal role is uncertain. This study used Mendelian randomization (MR) to investigate the causal effects of herpesvirus antibodies on ANDs.
Methods We assessed 22 herpesvirus antibodies and five ANDs—multiple sclerosis (MS), neuromyelitis optica (NMO), myasthenia gravis (MG), Guillain-Barr é syndrome (GBS), and chronic inflammatory demyelinating polyneuropathy (CIDP)—using five MR methods. MR-PRESSO, MR-Egger, and Cochran’s Q statistic identified pleiotropy and heterogeneity. Bonferroni correction set the significance threshold at P<4.545e-04. Validation used UK Biobank and FinnGen data, with meta-analysis for inconsistent results.
Results Significant positive causal effects were found for Epstein-Barr virus encoded nuclear antigen-1 (EBV EBNA-1) (OR=3.009), EBV viral capsid antigen (VCA) p18 (OR=8.700), and human herpesvirus 7(HHV7) U14 (OR=3.359) antibody levels on MS risk, and HHV7 U14 (OR=10.641), Varicella zoster virus glycoprotein E and glycoprotein I(VZV gE and gI) (OR=17.220) antibody levels on NMO risk. VZV gE and gI (OR=2.542) antibodies increased MG risk, while EBV ZEBRA (OR=0.592)reduced MS risk. Negative effects of EBV EA-D and ZEBRA antibodies on NMO were also noted. Validation confirmed the effects of EBV EBNA-1, EBV VCA p18 antibodies on MS, and VZV gE and gI on antibody MG, while EBV ZEBRA and HHV7 U14 antibodies effects on MS were not validated.
Conclusions The study suggests a causal link between specific herpesvirus antibodies and the risk of MS, NMO, and MG.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval and consent to participate Publicly available datasets were used for all data in our study. Informed consent was obtained from all participants prior to enrollment, and ethical approval was obtained for each cohort.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The original papers presented in this study can be found in the supplementary materials.
List of abbreviations
- ANDs
- Autoimmune neuroinflammatory diseases
- MS
- multiple sclerosis
- NMO
- neuromyelitis optica
- GBS
- Guillain-Barr é syndrome
- CIDP
- chronic inflammatory demyelinating polyneuropathy
- MG
- myasthenia gravis
- CNS
- central nervous system
- PNS
- peripheral nervous system
- NJM
- neuromuscular junction
- EBV
- Epstein-Barr virus
- HHV 6A
- Human herpesvirus 6A;
- CMV
- Cytomegalovirus
- AQP4 IgG+ NMOSD
- aquaporin-4 antibody-positive NMO spectrum disord
- MR
- mendelian randomisation
- HSV
- herpes simplex virus
- EBNA-1
- EBV encoded nuclear antigen-1
- EBV-VCA p18
- EBV viral capsid antigen p18
- VZV gE and gI
- Varicella zoster virus glycoprotein E and I
- GWAS
- Genome-Wide Association Study
- IMSGC
- International MS Genetics Consortium
- anti-AChR
- anti-acetylcholine receptor antibodies
- anti-MuSK
- antibodies to muscle-specific kinase
- SNPs
- single nucleotide polymorphisms
- MAF
- minor allele frequencies
- LD
- linkage disequilibrium
- BMI
- body mass index
- IVW
- Inverse Variance Weighte
- IVs
- instrumental variables (IVs)
- TSMR
- Two-Sample MR
- MR-PRESSO
- MR Egger intercept test and Outlier
- OR
- odds ratio
- CSF
- cerebrospinal fluid
- EAE
- experimental autoimmune encephalomyelitis.